DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 01 · Volume 53 · January 2015 DOI: 10.1055/s-005-28378


31. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
München, 30.–31. Januar 2015

Kongresspräsidentin: Prof. Dr. Ulrike Protzer – Kongresssekretär: Prof. Dr. Jacob Nattermann

  • A1_1
    Klein, S; Thies, SJ; Beck, J; Schierwagen, R; Masing, N; Hiththetiya, K; Schütz, E; Strassburg, CP; Sauerbruch, T; Trebicka, J:

    Rolle des Mas Rezeptors in der Leberfibrose

  • A1_2
    Othman, A; Friebel, A; Hoehme, S; Johanen, T; Begher-Tibbe, B; Drasdo, D; Hengstler, JG; Hammad, S:

    Three-dimensional reconstruction and quantification of key features of liver microarchitecture

  • A1_3
    Weng, HL; Liu, Y; Shen, Z; Hu, J; Feng, T; Dewidar, B; Park, O; Augustin, HG; Gao, B; Li, Y; Dooley, S:

    Delta like ligand4 ameliorates liver fibrogenesis through inhibiting chemokines

  • A1_4
  • A1_5
    Lutterbeck, M; Kleinehr, K; Driftmann, S; Treckmann, JW; Mathé, Z; Kaiser, G; Paul, A; Skibbe, K; Timm, J; Canbay, A; Gerken, G; Schlaak, JF; Broering, R:

    All-In-One: Advanced human parenchymal and non-parenchymal liver cell preparation

  • A1_6
  • A1_7
  • A1_8
    Martin, IV; Boor, P; Ostendorf, T; Floege, J; Lammert, F; Weber, SN:

    Comparative analysis of C5aR and C5L2 receptor deficiency in liver and kidney fibrosis

  • A1_9
  • A1_10
  • A1_11
    Görtzen, J; Klein, S; Schierwagen, R; Uschner, FE; Strassburg, CP; Laleman, W; Trebicka, J:

    Die Aktivität von cSRC bei der Leberfibrose

  • A1_12
  • A1_13
    Schierwagen, R; Heinzen, J; Granzow, M; Brägelmann, C; Klein, S; Uschner, FE; Hiththetiya, K; Strassburg, CP; Sauerbruch, T; Trebicka, J:

    Die Interaktion zwischen beta-Arrestin-2 und der AT1-Rezeptor abhängigen Signalkaskade in der Leberfibrose

  • A1_14
    Uschner, FE; Klein, S; Schierwagen, R; Tewes, B; Strassburg, CP; Kreisel, W; Sauerbruch, T; Trebicka, J:

    Effekte der akuten Gabe von Udenafil auf den Pfortaderdruck bei Ratten mit Leberzirrhose

  • A1_15
  • A1_16
  • A1_17
  • A1_18
  • A1_19
    Czech, B; Valletta, D; Thasler, W; Müller, M; Bosserhoff, A; Hellerbrand, C:

    Functional effects of monocarboxylate transporter 1 expression in activated hepatic stellate cells

  • A1_20
  • A1_21
  • A1_22
  • A1_23
  • A1_24
  • A1_25
    Camargo, RG; Henkel, J; Manowsky, J; Schanze, N; Coleman, D; Pathe-Neuschäfer-Rube, A; Seelaender, M; Püschel, GP:

    Impairment of insulin signaling in hepatocytes by supernatants of insulin-activated macrophages

  • A1_26
    Breitkopf-Heinlein, K; Ramachandran, SD; Schirmer, K; Ebert, M; Ghafoory, S; Wölfl, S; Münst, B; Heinz, S; Braspenning, J:

    In vitro generation of 3-dimensional organoid liver structures using differentiatedhuman cells

  • A1_27
    Czech, B; Valletta, D; Koch, A; Saugspier, M; Bosserhoff, A; Hellerbrand, C:

    Increased expression of the Glucose-transporter GLUT1 during hepatic stellate cell activation promotes hepatic fibrosis

  • A1_28
  • A1_29
  • A1_30
  • A1_31
    Jörs, S; Jeliazkova, P; Ringelhan, M; Thalhammer, J; Dürl, S; Ferrer, J; Sander, M; Heikenwälder, M; Schmid, RM; Siveke, JT; Geisler, F:

    Lineage fate of ductular reactions in liver injury and carcinogenesis

  • A1_32
    Asimakopoulou, A; Borkham-Kamphorst, E; Weiskirchen, R:

    Lipocalin 2 (LCN2) in hepatic inflammation

  • A1_33
    Andruszkow, JHK; Groos, S; Klaus, C; Schneider, U; Petersen, C; Gassler, N; Knüchel, R; Luciano, L:

    Loss of gap junctions in biliary atresia occurs simultaneously with declined expression of Protein kinase Cα

  • A1_34
    Altrock, E; Sens, C; Kawelke, N; Nakchbandi, IA:

    Loss of Integrin-β1 in Hepatocytes Induces Liver Fibrosis

  • A1_35
    Heinrichs, D; Knauel, M; Berres, ML; Fischer, P; Trautwein, C; Wasmuth, HE; Bernhagen, J:

    MIF shows profibrotic properties after MCD diet via NKT cell population

  • A1_36
    Böhmer, O; Ehlting, C; Hahnel, MJ; Thomas, M; Zanger, UM; Gaestel, M; Knoefel, WT; Schulte am Esch, J; Häussinger, D; Bode, JG:

    MK2 mediates induction and sensing of Oncostatin M-induced intercellular signalling in the liver but is dispensable for negative feedback regulation via SOCS3

  • A1_37
    Liebe, R; Breitkopf-Heinlein, K; Waldow, K; Braun, S; Thomas, M; Schildberg, F; Knolle, P; Zanger, U; Klingmüller, U; Ebert, M; Dooley, S:

    Mouse hepatic stellate cells are responsive to LPS and contribute to the acute phase response of hepatocytes

  • A1_38
    Boaru, SG; Borkham-Kamphorst, E; Van de Leur, E; Liedtke, C; Weiskirchen, R:

    NLRP3 inflammasome expression in cultured hepatocytes is regulated by nuclear factor-κB (NF-κB)

  • A1_39
  • A1_40
  • A1_41
  • A1_42
    Vartak, A; Richter, B; Dahmen, U; Dirsch, O; Hengstler, JG; Hammad, S:

    Reconstruction and quantification of periportal bile ducts and Hering canal after bile duct ligation

  • A1_43
  • A1_44
  • A1_45
  • A1_46
    Dropmann, A; Korhonen, H; Jaschinski, F; Janicot, M; Meindl-Beinker, N; Dooley, S:

    Targeting TGF-β2 in chronic liver diseases

  • A1_47
  • A1_48
    Huang, J; Macheleidt, I; Perrech, M; Noetel, A; Dienes, HP; Hescheler, J; Büttner, R; Saric, T; Odenthal, M:

    The pluripotency involved factors, Lin28 and Notch1 are targets of neuronal miRNAs in hepatic stellate cells

  • A1_49
    Henkel, J; Lieske, S; Camargo, RG; Schanze, N; Sauer, I; Birkenfeld, AL; Püschel, GP:

    The vicious circle of prostaglandin- and cytokine-dependent hepatic insulin resistance: a key role of prostaglandin E2

  • A1_50
  • A1_51
  • A1_52
    Weiskirchen, R; Hermert, D; Alidousty, C; Ostendorf, T; Floege, J; Raffetseder, U:

    Y-box-binding protein (YB-1) in murine models of hepatic and renal fibrosis

  • A1_53
    Jansen, C; Reiberger, T; Schierwagen, R; Mandorfer, M; Anadol, E; Schwabl, P; Wasmuth, JC; Strassburg, CP; Rockstroh, J; Peck-Radosavljevic, M; Odenthal, M; Trebicka, J:

    Zusammenhang der zirkulierenden miRNA-122 Spiegel mit der portalen Hypertension bei HIV/HCV-positiven Patienten